세계의 의약품용 지질 기반 부형제 시장 보고서(2025년)

Pharmaceutical lipid-based excipients are inactive substances derived from lipids that are used in drug formulations to aid in the delivery, stabilization, or enhancement of the absorption of the active pharmaceutical ingredient (API). These excipients are designed to improve the solubility, stability, and bioavailability of drugs, especially those that are poorly soluble in water.

The main types of pharmaceutical lipid-based excipients include oils, hydrogenated vegetable oils, glyceryl mono caprylate/caprate (GMCC), hard fats, medium-chain triglycerides, lecithin and phospholipids, sodium oleate, caprylic mono- and diglycerides, and others. Oils serve as non-aqueous carriers, enhancing the solubility of lipophilic drugs and improving their oral bioavailability. These excipients are used in various formulations such as oral, parenteral, topical, ophthalmic applications, suppositories, and more. They are employed in the treatment of a broad range of conditions, including cardiovascular diseases, neurological disorders, cancer, metabolic disorders, hormonal imbalances, and infectious diseases. Lipid-based excipients are formulated for all age groups pediatric (0-18 years), adult (19-64 years), and geriatric (65+ years). The key end users include pharmaceutical manufacturers, contract development and manufacturing organizations (CDMOs), and others.

The pharmaceutical lipid-based excipients treatment market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical lipid-based excipients treatment market statistics, including the pharmaceutical lipid-based excipients treatment industry global market size, regional shares, competitors with the pharmaceutical lipid-based excipients treatment market share, detailed pharmaceutical lipid-based excipients treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the pharmaceutical lipid-based excipients treatment industry. This pharmaceutical lipid-based excipients treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pharmaceutical lipid-based excipients market size has grown strongly in recent years. It will grow from $1.69 billion in 2024 to $1.79 billion in 2025 at a compound annual growth rate (CAGR) of 5.8%. The growth during the historic period can be attributed to several factors, including the increasing prevalence of poorly water-soluble drugs, higher demand for controlled and targeted drug release, a rise in pharmaceutical investments, the expansion of oral solid dosage forms, a greater focus on improving drug bioavailability, and the regulatory acceptance of lipid excipients in innovative formulations.

The pharmaceutical lipid-based excipients market size is expected to see strong growth in the next few years. It will grow to $2.22 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%. The growth during the forecast period can be attributed to the increasing demand for advanced drug delivery systems, the growing adoption of mRNA and gene therapies, an expanding pipeline of poorly water-soluble drugs, a stronger focus on personalized medicine, supportive regulatory frameworks, and strategic investments in biopharmaceutical manufacturing infrastructure. Key trends during this period include innovations in lipid nanoparticle delivery systems, wider adoption of mRNA and gene therapies, enhanced solubility solutions for poorly water-soluble drugs, the expansion of biocompatible and sustainable lipid sources, improved manufacturing scalability, and greater use in oral and injectable formulations.

The growth of gene therapy is expected to accelerate the expansion of the pharmaceutical lipid-based excipients market. Gene therapy involves modifying or manipulating a person's genes to treat or prevent disease. Its rise is largely driven by advancements in delivery systems that ensure safe, efficient, and targeted transport of genetic material into cells. Pharmaceutical lipid-based excipients play a crucial role in enhancing gene therapy by enabling efficient delivery systems, providing stability, and ensuring the targeted transport of genetic material. These excipients improve therapeutic outcomes by protecting nucleic acids and facilitating cellular uptake, thereby increasing the effectiveness of modern treatments. For example, in December 2024, the American Society of Gene & Cell Therapy (ASGCT), a U.S.-based non-profit organization, reported that the U.S. Food and Drug Administration (FDA) approved six gene therapy products in 2023, up from five in 2022. This growing trend in gene therapy is driving the demand for pharmaceutical lipid-based excipients.

Leading companies in the pharmaceutical lipid-based excipients market are making strategic investments to foster innovation, enhance formulation capabilities, and support drug delivery research. A notable example is Gattefosse SAS, a France-based chemical manufacturing company, which opened a state-of-the-art Technical Center of Excellence in Mumbai in November 2024. This facility aims to support India's growing pharmaceutical market, offering specialized laboratories and tailored support for excipient innovation, particularly in bioavailability, sustained release, and topical formulations. It will also strengthen Gattefosse's position in the Asia-Pacific region. The new facility is designed to encourage collaboration and foster innovation, providing a productive environment for research in pharmaceutical and personal care applications.

In June 2024, CordenPharma, a pharmaceutical company based in Switzerland, formed a partnership with Certest Biotec S.L., a Spain-based biotechnology company. The collaboration aims to integrate Certest's proprietary ionizable lipids into CordenPharma's lipid nanoparticle (LNP) formulation services. This partnership is set to enhance the development of RNA/DNA-based therapeutics by combining the expertise of both companies in lipid innovation, manufacturing, and regulatory compliance. Certest Biotec specializes in drug delivery through lipid nanoparticles (LNPs) and the synthesis of active pharmaceutical ingredients (APIs).

Major players in the pharmaceutical lipid-based excipients market are Cargill Incorporated, BASF SE, Merck KGaA, FUJIFILM Corporation, Evonik Industries AG, DuPont de Nemours Inc., Stepan Company, Croda International, Ashland Corporation, NOF CORPORATION, CordenPharma, SEPPIC, Nippon Fine Chemical Co. Ltd., Cayman Chemical, ABITEC Corporation, Creative Biolabs, IOI Oleo GmbH, Lipoid, RuixiBiotechCo.Ltd, Biosynth.

Europe was the largest region in the pharmaceutical lipid-based excipients market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pharmaceutical lipid-based excipients report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the pharmaceutical lipid-based excipients market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pharmaceutical lipid-based excipients market consists of sales of lipid excipients, specialty formulations, sterols, waxes, and glycolipids. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmaceutical Lipid-Based Excipients Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pharmaceutical lipid-based excipients market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharmaceutical lipid-based excipients ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharmaceutical lipid-based excipients market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Excipient Type: Oils; Hydrogenated Vegetable Oils; GMCC; Hard Fats; Medium Chain Triglycerides; Lecithin And Phospholipids; Sodium Oleate; Capri Caprylic Mono Diglyceride; Other Excipient Types
• 2) By Product Applications: Oral Formulations; Parenteral; Topical Applications; Ophthalmic Applications; Suppositories; Other Product Applications
• 3) By Disease Application: Cardiovascular Diseases; Neurological Disorders; Oncology; Metabolic Disorders; Hormonal Therapies; Infectious Diseases; Other Disease Applications
• 4) By Age Group: Pediatric Products (0-18 years); Adult Products (19-64 years); Geriatric Products (65+ years)
• 5) By End-Use: Pharmaceutical Manufacturers; Contract Development And Manufacturing Organizations; Other End Users
• Subsegments:
• 1) By Oils: Soybean Oil; Olive Oil; Palm Oil; Sunflower Oil; Other Oils
• 2) By Hydrogenated Vegetable Oils: Hydrogenated Soybean Oil; Hydrogenated Palm Oil; Hydrogenated Cottonseed Oil; Other Hydrogenated Vegetable Oils
• 3) By GMCC (Glyceryl Mono/Diesters of C16/C18): Glyceryl Monostearate; Glyceryl Distearate; Glyceryl Monopalmitate; Other GMCC
• 4) By Hard Fats: Hydrogenated Castor Oil; Hydrogenated Palm Kernel Oil; Hydrogenated Coconut Oil; Other Hard Fats
• 5) By Medium Chain Triglycerides (MCTs): Capric Triglycerides; Caprylic Triglycerides; Caprylic-Capric Triglycerides; Other MCTs
• 6) By Lecithin and Phospholipids: Soy Lecithin; Egg Lecithin; Phosphatidylcholine; Phosphatidylserine; Other Lecithin and Phospholipids
• 7) By Sodium Oleate: Pharmaceutical Grade Sodium Oleate; Food Grade Sodium Oleate; Industrial Grade Sodium Oleate
• 8) By Capri-Caprylic Mono/Diglycerides: Capric-Caprylic Monoglycerides; Capric-Caprylic Diglycerides
• 9) By Other Excipient Types: Sucrose Esters; Fatty Acid Esters; PEGylated Lipids; Other Miscellaneous Lipids
• Companies Mentioned: Cargill Incorporated; BASF SE; Merck KGaA; FUJIFILM Corporation; Evonik Industries AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pharmaceutical Lipid-Based Excipients Market Characteristics

3. Pharmaceutical Lipid-Based Excipients Market Trends And Strategies

4. Pharmaceutical Lipid-Based Excipients Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Pharmaceutical Lipid-Based Excipients Growth Analysis And Strategic Analysis Framework

• 5.1. Global Pharmaceutical Lipid-Based Excipients PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Pharmaceutical Lipid-Based Excipients Market Growth Rate Analysis
• 5.4. Global Pharmaceutical Lipid-Based Excipients Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Pharmaceutical Lipid-Based Excipients Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Pharmaceutical Lipid-Based Excipients Total Addressable Market (TAM)

6. Pharmaceutical Lipid-Based Excipients Market Segmentation

• 6.1. Global Pharmaceutical Lipid-Based Excipients Market, Segmentation By Excipient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oils
• Hydrogenated Vegetable Oils
• GMCC
• Hard Fats
• Medium Chain Triglycerides
• Lecithin And Phospholipids
• Sodium Oleate
• Capri Caprylic Mono Diglyceride
• Other Excipient Types
• 6.2. Global Pharmaceutical Lipid-Based Excipients Market, Segmentation By Product Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Formulations
• Parenteral
• Topical Applications
• Ophthalmic Applications
• Suppositories
• Other Product Applications
• 6.3. Global Pharmaceutical Lipid-Based Excipients Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cardiovascular Diseases
• Neurological Disorders
• Oncology
• Metabolic Disorders
• Hormonal Therapies
• Infectious Diseases
• Other Disease Applications
• 6.4. Global Pharmaceutical Lipid-Based Excipients Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pediatric Products (0-18 years)
• Adult Products (19-64 years)
• Geriatric Products (65+ years)
• 6.5. Global Pharmaceutical Lipid-Based Excipients Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical Manufacturers
• Contract Development And Manufacturing Organizations
• Other End Users
• 6.6. Global Pharmaceutical Lipid-Based Excipients Market, Sub-Segmentation Of Oils, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Soybean Oil
• Olive Oil
• Palm Oil
• Sunflower Oil
• Other Oils
• 6.7. Global Pharmaceutical Lipid-Based Excipients Market, Sub-Segmentation Of Hydrogenated Vegetable Oils, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hydrogenated Soybean Oil
• Hydrogenated Palm Oil
• Hydrogenated Cottonseed Oil
• Other Hydrogenated Vegetable Oils
• 6.8. Global Pharmaceutical Lipid-Based Excipients Market, Sub-Segmentation Of GMCC (Glyceryl Mono Or Diesters Of C16/C18), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Glyceryl Monostearate
• Glyceryl Distearate
• Glyceryl Monopalmitate
• Other GMCC
• 6.9. Global Pharmaceutical Lipid-Based Excipients Market, Sub-Segmentation Of Hard Fats, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hydrogenated Castor Oil
• Hydrogenated Palm Kernel Oil
• Hydrogenated Coconut Oil
• Other Hard Fats
• 6.10. Global Pharmaceutical Lipid-Based Excipients Market, Sub-Segmentation Of Medium Chain Triglycerides (MCTs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Capric Triglycerides
• Caprylic Triglycerides
• Caprylic-Capric Triglycerides
• Other MCTs
• 6.11. Global Pharmaceutical Lipid-Based Excipients Market, Sub-Segmentation Of Lecithin And Phospholipids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Soy Lecithin
• Egg Lecithin
• Phosphatidylcholine
• Phosphatidylserine
• Other Lecithin And Phospholipids
• 6.12. Global Pharmaceutical Lipid-Based Excipients Market, Sub-Segmentation Of Sodium Oleate, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical Grade Sodium Oleate
• Food Grade Sodium Oleate
• Industrial Grade Sodium Oleate
• 6.13. Global Pharmaceutical Lipid-Based Excipients Market, Segmentation By Capri-Caprylic Mono Or Diglycerides, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Capric-Caprylic Monoglycerides
• Capric-Caprylic Diglycerides
• 6.14. Global Pharmaceutical Lipid-Based Excipients Market, Sub-Segmentation Of Other Excipient Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sucrose Esters
• Fatty Acid Esters
• PEGylated Lipids
• Other Miscellaneous Lipids

7. Pharmaceutical Lipid-Based Excipients Market Regional And Country Analysis

• 7.1. Global Pharmaceutical Lipid-Based Excipients Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Pharmaceutical Lipid-Based Excipients Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pharmaceutical Lipid-Based Excipients Market

• 8.1. Asia-Pacific Pharmaceutical Lipid-Based Excipients Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Pharmaceutical Lipid-Based Excipients Market, Segmentation By Excipient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Pharmaceutical Lipid-Based Excipients Market, Segmentation By Product Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Pharmaceutical Lipid-Based Excipients Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pharmaceutical Lipid-Based Excipients Market

• 9.1. China Pharmaceutical Lipid-Based Excipients Market Overview
• 9.2. China Pharmaceutical Lipid-Based Excipients Market, Segmentation By Excipient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Pharmaceutical Lipid-Based Excipients Market, Segmentation By Product Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Pharmaceutical Lipid-Based Excipients Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pharmaceutical Lipid-Based Excipients Market

• 10.1. India Pharmaceutical Lipid-Based Excipients Market, Segmentation By Excipient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Pharmaceutical Lipid-Based Excipients Market, Segmentation By Product Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Pharmaceutical Lipid-Based Excipients Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pharmaceutical Lipid-Based Excipients Market

• 11.1. Japan Pharmaceutical Lipid-Based Excipients Market Overview
• 11.2. Japan Pharmaceutical Lipid-Based Excipients Market, Segmentation By Excipient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Pharmaceutical Lipid-Based Excipients Market, Segmentation By Product Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Pharmaceutical Lipid-Based Excipients Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pharmaceutical Lipid-Based Excipients Market

• 12.1. Australia Pharmaceutical Lipid-Based Excipients Market, Segmentation By Excipient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Pharmaceutical Lipid-Based Excipients Market, Segmentation By Product Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Pharmaceutical Lipid-Based Excipients Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pharmaceutical Lipid-Based Excipients Market

• 13.1. Indonesia Pharmaceutical Lipid-Based Excipients Market, Segmentation By Excipient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Pharmaceutical Lipid-Based Excipients Market, Segmentation By Product Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Pharmaceutical Lipid-Based Excipients Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pharmaceutical Lipid-Based Excipients Market

• 14.1. South Korea Pharmaceutical Lipid-Based Excipients Market Overview
• 14.2. South Korea Pharmaceutical Lipid-Based Excipients Market, Segmentation By Excipient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Pharmaceutical Lipid-Based Excipients Market, Segmentation By Product Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Pharmaceutical Lipid-Based Excipients Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pharmaceutical Lipid-Based Excipients Market

• 15.1. Western Europe Pharmaceutical Lipid-Based Excipients Market Overview
• 15.2. Western Europe Pharmaceutical Lipid-Based Excipients Market, Segmentation By Excipient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Pharmaceutical Lipid-Based Excipients Market, Segmentation By Product Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Pharmaceutical Lipid-Based Excipients Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pharmaceutical Lipid-Based Excipients Market

• 16.1. UK Pharmaceutical Lipid-Based Excipients Market, Segmentation By Excipient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Pharmaceutical Lipid-Based Excipients Market, Segmentation By Product Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Pharmaceutical Lipid-Based Excipients Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pharmaceutical Lipid-Based Excipients Market

• 17.1. Germany Pharmaceutical Lipid-Based Excipients Market, Segmentation By Excipient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Pharmaceutical Lipid-Based Excipients Market, Segmentation By Product Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Pharmaceutical Lipid-Based Excipients Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pharmaceutical Lipid-Based Excipients Market

• 18.1. France Pharmaceutical Lipid-Based Excipients Market, Segmentation By Excipient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Pharmaceutical Lipid-Based Excipients Market, Segmentation By Product Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Pharmaceutical Lipid-Based Excipients Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pharmaceutical Lipid-Based Excipients Market

• 19.1. Italy Pharmaceutical Lipid-Based Excipients Market, Segmentation By Excipient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Pharmaceutical Lipid-Based Excipients Market, Segmentation By Product Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Pharmaceutical Lipid-Based Excipients Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pharmaceutical Lipid-Based Excipients Market

• 20.1. Spain Pharmaceutical Lipid-Based Excipients Market, Segmentation By Excipient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Pharmaceutical Lipid-Based Excipients Market, Segmentation By Product Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Pharmaceutical Lipid-Based Excipients Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pharmaceutical Lipid-Based Excipients Market

• 21.1. Eastern Europe Pharmaceutical Lipid-Based Excipients Market Overview
• 21.2. Eastern Europe Pharmaceutical Lipid-Based Excipients Market, Segmentation By Excipient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Pharmaceutical Lipid-Based Excipients Market, Segmentation By Product Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Pharmaceutical Lipid-Based Excipients Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pharmaceutical Lipid-Based Excipients Market

• 22.1. Russia Pharmaceutical Lipid-Based Excipients Market, Segmentation By Excipient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Pharmaceutical Lipid-Based Excipients Market, Segmentation By Product Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Pharmaceutical Lipid-Based Excipients Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pharmaceutical Lipid-Based Excipients Market

• 23.1. North America Pharmaceutical Lipid-Based Excipients Market Overview
• 23.2. North America Pharmaceutical Lipid-Based Excipients Market, Segmentation By Excipient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Pharmaceutical Lipid-Based Excipients Market, Segmentation By Product Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Pharmaceutical Lipid-Based Excipients Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pharmaceutical Lipid-Based Excipients Market

• 24.1. USA Pharmaceutical Lipid-Based Excipients Market Overview
• 24.2. USA Pharmaceutical Lipid-Based Excipients Market, Segmentation By Excipient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Pharmaceutical Lipid-Based Excipients Market, Segmentation By Product Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Pharmaceutical Lipid-Based Excipients Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pharmaceutical Lipid-Based Excipients Market

• 25.1. Canada Pharmaceutical Lipid-Based Excipients Market Overview
• 25.2. Canada Pharmaceutical Lipid-Based Excipients Market, Segmentation By Excipient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Pharmaceutical Lipid-Based Excipients Market, Segmentation By Product Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Pharmaceutical Lipid-Based Excipients Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pharmaceutical Lipid-Based Excipients Market

• 26.1. South America Pharmaceutical Lipid-Based Excipients Market Overview
• 26.2. South America Pharmaceutical Lipid-Based Excipients Market, Segmentation By Excipient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Pharmaceutical Lipid-Based Excipients Market, Segmentation By Product Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Pharmaceutical Lipid-Based Excipients Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pharmaceutical Lipid-Based Excipients Market

• 27.1. Brazil Pharmaceutical Lipid-Based Excipients Market, Segmentation By Excipient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Pharmaceutical Lipid-Based Excipients Market, Segmentation By Product Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Pharmaceutical Lipid-Based Excipients Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pharmaceutical Lipid-Based Excipients Market

• 28.1. Middle East Pharmaceutical Lipid-Based Excipients Market Overview
• 28.2. Middle East Pharmaceutical Lipid-Based Excipients Market, Segmentation By Excipient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Pharmaceutical Lipid-Based Excipients Market, Segmentation By Product Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Pharmaceutical Lipid-Based Excipients Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pharmaceutical Lipid-Based Excipients Market

• 29.1. Africa Pharmaceutical Lipid-Based Excipients Market Overview
• 29.2. Africa Pharmaceutical Lipid-Based Excipients Market, Segmentation By Excipient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Pharmaceutical Lipid-Based Excipients Market, Segmentation By Product Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Pharmaceutical Lipid-Based Excipients Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pharmaceutical Lipid-Based Excipients Market Competitive Landscape And Company Profiles

• 30.1. Pharmaceutical Lipid-Based Excipients Market Competitive Landscape
• 30.2. Pharmaceutical Lipid-Based Excipients Market Company Profiles
  • 30.2.1. Cargill Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. BASF SE Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. FUJIFILM Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Evonik Industries AG Overview, Products and Services, Strategy and Financial Analysis

31. Pharmaceutical Lipid-Based Excipients Market Other Major And Innovative Companies

• 31.1. DuPont de Nemours Inc.
• 31.2. Stepan Company
• 31.3. Croda International
• 31.4. Ashland Corporation
• 31.5. NOF CORPORATION
• 31.6. CordenPharma
• 31.7. SEPPIC
• 31.8. Nippon Fine Chemical Co. Ltd.
• 31.9. Cayman Chemical
• 31.10. ABITEC Corporation
• 31.11. Creative Biolabs
• 31.12. IOI Oleo GmbH
• 31.13. Lipoid
• 31.14. RuixiBiotechCo.Ltd
• 31.15. Biosynth

32. Global Pharmaceutical Lipid-Based Excipients Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pharmaceutical Lipid-Based Excipients Market

34. Recent Developments In The Pharmaceutical Lipid-Based Excipients Market

35. Pharmaceutical Lipid-Based Excipients Market High Potential Countries, Segments and Strategies

• 35.1 Pharmaceutical Lipid-Based Excipients Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Pharmaceutical Lipid-Based Excipients Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Pharmaceutical Lipid-Based Excipients Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer